FDA To Yank Marketing Approval For Menaflex Device
The U.S. Food and Drug Administration revealed Thursday that it is planning to rescind its erroneous marketing clearance for a ReGen Biologics Inc. knee device, following the release of a report...To view the full article, register now.
Already a subscriber? Click here to view full article